Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021

Upgrades

For CVR Energy Inc CVI, Credit Suisse upgraded the previous rating of Underperform to Neutral. In the third quarter, CVR Energy showed an EPS of $0.57, compared to $1.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $35.63 and a 52-week-low of $9.81. CVR Energy closed at $21.13 at the end of the last trading period.
Credit Suisse upgraded the previous rating for Par Pacific Holdings Inc PARR from Underperform to Neutral. In the third quarter, Par Pacific Hldgs showed an EPS of $1.06, compared to $0.13 from the year-ago quarter. The stock has a 52-week-high of $20.43 and a 52-week-low of $5.72. At the end of the last trading period, Par Pacific Hldgs closed at $15.40.
RBC Capital upgraded the previous rating for Bausch Health Companies Inc BHC from Sector Perform to Outperform. In the third quarter, Bausch Health Cos showed an EPS of $1.32, compared to $1.19 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.25 and a 52-week-low of $11.15. Bausch Health Cos closed at $31.48 at the end of the last trading period.
For Black Knight Inc BKI, Susquehanna upgraded the previous rating of Neutral to Positive. Black Knight earned $0.60 in the fourth quarter, compared to $0.54 in the year-ago quarter. The current stock performance of Black Knight shows a 52-week-high of $97.19 and a 52-week-low of $50.01. Moreover, at the end of the last trading period, the closing price was at $82.05.
For Anterix Inc ATEX, JP Morgan upgraded the previous rating of Neutral to Overweight. At the moment, the stock has a 52-week-high of $57.75 and a 52-week-low of $27.27. Anterix closed at $40.55 at the end of the last trading period.
According to Jefferies, the prior rating for Oshkosh Corp OSK was changed from Hold to Buy. In the first quarter, Oshkosh showed an EPS of $1.13, compared to $1.10 from the year-ago quarter. The stock has a 52-week-high of $100.77 and a 52-week-low of $46.72. At the end of the last trading period, Oshkosh closed at $99.14.
For Palantir Technologies Inc PLTR, Goldman Sachs upgraded the previous rating of Neutral to Buy. In the fourth quarter, Palantir Technologies earned $0.06. The current stock performance of Palantir Technologies shows a 52-week-high of $45.00 and a 52-week-low of $8.90. Moreover, at the end of the last trading period, the closing price was at $27.84.
KeyBanc upgraded the previous rating for Rexnord Corp RXN from Sector Weight to Overweight. In the third quarter, Rexnord showed an EPS of $0.39, compared to $0.48 from the year-ago quarter. The current stock performance of Rexnord shows a 52-week-high of $49.08 and a 52-week-low of $18.87. Moreover, at the end of the last trading period, the closing price was at $45.11.
According to KeyBanc, the prior rating for Regal Beloit Corp RBC was changed from Sector Weight to Overweight. For the fourth quarter, Regal Beloit had an EPS of $1.78, compared to year-ago quarter EPS of $1.25. The current stock performance of Regal Beloit shows a 52-week-high of $146.97 and a 52-week-low of $51.99. Moreover, at the end of the last trading period, the closing price was at $133.19.

See all analyst ratings upgrades.

Downgrades

Truist Securities downgraded the previous rating for KAR Auction Services Inc KAR from Buy to Hold. For the fourth quarter, KAR Auction Services had an EPS of $0.01, compared to year-ago quarter EPS of $0.19. The current stock performance of KAR Auction Services shows a 52-week-high of $23.53 and a 52-week-low of $9.41. Moreover, at the end of the last trading period, the closing price was at $18.45.
Roth Capital downgraded the previous rating for Kodiak Sciences Inc KOD from Buy to Neutral. In the third quarter, Kodiak Sciences showed an EPS of $0.80, compared to $0.33 from the year-ago quarter. At the moment, the stock has a 52-week-high of $171.21 and a 52-week-low of $35.49. Kodiak Sciences closed at $145.58 at the end of the last trading period.
For KAR Auction Services Inc KAR, Guggenheim downgraded the previous rating of Neutral to Sell. KAR Auction Services earned $0.01 in the fourth quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.53 and a 52-week-low of $9.41. KAR Auction Services closed at $18.45 at the end of the last trading period.
For Palantir Technologies Inc PLTR, William Blair downgraded the previous rating of Market Perform to Underperform. Palantir Technologies earned $0.06 in the fourth quarter. The stock has a 52-week-high of $45.00 and a 52-week-low of $8.90. At the end of the last trading period, Palantir Technologies closed at $27.84.
Morgan Stanley downgraded the previous rating for Fortive Corp FTV from Overweight to Equal-Weight. For the fourth quarter, Fortive had an EPS of $0.70, compared to year-ago quarter EPS of $1.03. At the moment, the stock has a 52-week-high of $82.12 and a 52-week-low of $37.31. Fortive closed at $69.85 at the end of the last trading period.
For Cortexyme Inc CRTX, Jefferies downgraded the previous rating of Buy to Hold. In the third quarter, Cortexyme showed an EPS of $0.73, compared to $0.37 from the year-ago quarter. The current stock performance of Cortexyme shows a 52-week-high of $73.84 and a 52-week-low of $26.66. Moreover, at the end of the last trading period, the closing price was at $30.72.
JP Morgan downgraded the previous rating for bluebird bio Inc BLUE from Overweight to Neutral. For the third quarter, bluebird bio had an EPS of $2.94, compared to year-ago quarter EPS of $3.73. The stock has a 52-week-high of $90.63 and a 52-week-low of $26.11. At the end of the last trading period, bluebird bio closed at $28.44.

See all analyst ratings downgrades.

Initiations

With an Overweight rating, Wells Fargo initiated coverage on Chesapeake Energy Corp CHK. The price target seems to have been set at $54.00 for Chesapeake Energy. The current stock performance of Chesapeake Energy shows a 52-week-high of $77.50 and a 52-week-low of $0.12. Moreover, at the end of the last trading period, the closing price was at $43.55.
Roth Capital initiated coverage on DiaMedica Therapeutics Inc DMAC with a Buy rating. The price target for DiaMedica Therapeutics is set to $38.00. For the third quarter, DiaMedica Therapeutics had an EPS of $0.19, compared to year-ago quarter EPS of $0.20. The current stock performance of DiaMedica Therapeutics shows a 52-week-high of $10.88 and a 52-week-low of $1.87. Moreover, at the end of the last trading period, the closing price was at $9.40.
Needham initiated coverage on Cormedix Inc CRMD with a Buy rating. The price target for Cormedix is set to $31.00. The stock has a 52-week-high of $17.14 and a 52-week-low of $2.16. At the end of the last trading period, Cormedix closed at $13.99.
With an Outperform rating, BMO Capital initiated coverage on Phathom Pharmaceuticals Inc PHAT. The price target seems to have been set at $63.00 for Phathom Pharmaceuticals. Phathom Pharmaceuticals earned $1.02 in the third quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $64.54 and a 52-week-low of $22.06. At the end of the last trading period, Phathom Pharmaceuticals closed at $42.80.
With an Overweight rating, Barclays initiated coverage on IDEXX Laboratories Inc IDXX. The price target seems to have been set at $600.00 for IDEXX Laboratories. IDEXX Laboratories earned $1.76 in the fourth quarter, compared to $1.04 in the year-ago quarter. The current stock performance of IDEXX Laboratories shows a 52-week-high of $548.58 and a 52-week-low of $168.65. Moreover, at the end of the last trading period, the closing price was at $538.16.
With an Overweight rating, Barclays initiated coverage on Covetrus Inc CVET. The price target seems to have been set at $48.00 for Covetrus. For the third quarter, Covetrus had an EPS of $0.26, compared to year-ago quarter EPS of $0.17. The stock has a 52-week-high of $40.77 and a 52-week-low of $4.04. At the end of the last trading period, Covetrus closed at $37.58.
With a Buy rating, DA Davidson initiated coverage on First Citizens BancShares Inc FCNCA. The price target seems to have been set at $875.00 for First Citizens BancShares. First Citizens BancShares earned $13.59 in the fourth quarter, compared to $9.55 in the year-ago quarter. The current stock performance of First Citizens BancShares shows a 52-week-high of $749.50 and a 52-week-low of $276.08. Moreover, at the end of the last trading period, the closing price was at $746.00.
With a Buy rating, HC Wainwright & Co. initiated coverage on Oncolytics Biotech Inc ONCY. The price target seems to have been set at $15.00 for Oncolytics Biotech. For the third quarter, Oncolytics Biotech had an EPS of $0.12, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $4.19 and a 52-week-low of $0.94. At the end of the last trading period, Oncolytics Biotech closed at $3.01.
Goldman Sachs initiated coverage on Patria Investments Ltd PAX with a Buy rating. The price target for Patria Investments is set to $28.00. The stock has a 52-week-high of $23.28 and a 52-week-low of $17.23. At the end of the last trading period, Patria Investments closed at $22.38.
With a Buy rating, BTIG initiated coverage on Vuzix Corporation VUZI. The price target seems to have been set at $30.00 for Vuzix. For the third quarter, Vuzix had an EPS of $0.13, compared to year-ago quarter EPS of $0.18. The current stock performance of Vuzix shows a 52-week-high of $17.36 and a 52-week-low of $0.86. Moreover, at the end of the last trading period, the closing price was at $17.16.
KeyBanc initiated coverage on Howmet Aerospace Inc HWM with an Overweight rating. The price target for Howmet Aerospace is set to $36.00. For the fourth quarter, Howmet Aerospace had an EPS of $0.21, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $29.10 and a 52-week-low of $9.87. At the end of the last trading period, Howmet Aerospace closed at $28.37.